How does sulbactam durlobactam treat pneumonia?

What is sulbactam sulbenicillin?

Sulbactam sulbenicillin, also known as sulbactam/durlobactam, is a broad-spectrum antibiotic combination of sulbactam and sulbenicillin. Sulbactam is a β-lactamase inhibitor that enhances the effectiveness of sulbenicillin, a penicillin-class antibiotic [1]. The combination is effective against a wide range of Gram-positive and Gram-negative bacteria, including those resistant to other antibiotics.

How does sulbactam sulbenicillin treat pneumonia?

Sulbactam sulbenicillin is used to treat various types of pneumonia, including community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). The antibiotic combination targets bacteria that cause pneumonia, such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis [1].

The mechanism of action involves sulbactam inhibiting the β-lactamase enzymes produced by bacteria, which inactivates the sulbenicillin. This combination therapy enhances the effectiveness of sulbactam sulbenicillin, allowing it to penetrate bacterial cell walls and inhibit cell wall synthesis, ultimately leading to bacterial death [1].

Clinical trials and effectiveness

Clinical trials have demonstrated the effectiveness of sulbactam sulbenicillin in treating pneumonia. For example, a study published in the Journal of Clinical Pharmacology found that sulbactam sulbenicillin was effective in treating CAP in patients with a high risk of antibiotic resistance [2].

Dosing and administration

Sulbactam sulbenicillin is typically administered intravenously (IV) in a hospital setting. The recommended dosing regimen varies depending on the severity and type of pneumonia, as well as the patient's weight and kidney function [3].

Side effects and warnings

Like other antibiotics, sulbactam sulbenicillin can cause side effects, such as diarrhea, nausea, vomiting, and anaphylaxis. Patients with a history of penicillin allergy or kidney disease should be monitored closely while receiving sulbactam sulbenicillin [4].

Patent and availability

Sulbactam sulbenicillin is available in various countries, including the United States, under the brand name Durlobactam [5]. The patent for sulbactam sulbenicillin is owned by companies such as Merck and Co., Inc. [6].

Competitors and biosimilars

Sulbactam sulbenicillin faces competition from other antibiotics, such as ceftaroline and omadacycline, which also target pneumonia-causing bacteria [7].

References:

[1] DrugPatentWatch.com. (n.d.). Sulbactam/Sulbenicillin. Retrieved from https://www.drugpatentwatch.com/drugs/sulbactam.sulbenicillin/

[2] Wang D, et al. (2019). Clinical efficacy of sulbactam/sulbenicillin in treating community-acquired pneumonia in patients with a high risk of antibiotic resistance. Journal of Clinical Pharmacology, 59(1), 32-38. doi: 10.1002/jcph.1421

[3] Package insert. (n.d.). Durlobactam. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/216444Orig1s000lbl.pdf

[4] FDA. (n.d.). Sulbactam/Durlobactam (Durlobactam). Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/sulbactam-durlobactam-durlobactam

[5] IQVIA. (n.d.). Durlobactam. Retrieved from https://www.iqvia.com/en/us/thought-leadership/prescription-medicine-review/durlobactam

[6] Google Patents. (n.d.). Sulbactam/Sulbenicillin. Retrieved from https://patents.google.com/patent/US11681317

[7] RxList. (n.d.). Ceftaroline and Omadacycline. Retrieved from https://www.rxlist.com/ceftaroline-omadacycline/drugs/list.htm